S Mathieu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S Mathieu

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Anticancer Research|August 12, 2009

Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancerJohn N Flanagan, Shasha Zheng, Kun-Chun Chiang, et al.

Journal Des Maladies Vasculaires|June 26, 2012

[Screening for asymptomatic peripheral arterial occlusive disease of the lower limbs by measuring the ankle-brachial index in the general population (Senegal)]S Pessinaba, A Mbaye, Ad Kane, et al.

Annales De Cardiologie Et D'Angeiologie|April 2, 2013

[Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal)]S Pessinaba, A Mbaye, G A D Yabéta, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Anticancer Research|August 12, 2009

Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancerJohn N Flanagan, Shasha Zheng, Kun-Chun Chiang, et al.

Journal Des Maladies Vasculaires|June 26, 2012

[Screening for asymptomatic peripheral arterial occlusive disease of the lower limbs by measuring the ankle-brachial index in the general population (Senegal)]S Pessinaba, A Mbaye, Ad Kane, et al.

Annales De Cardiologie Et D'Angeiologie|April 2, 2013

[Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal)]S Pessinaba, A Mbaye, G A D Yabéta, et al.

Pageof 7